Managers / Q3 2019 · view latest →
Galibier Capital Management Ltd.
CIK 0001765768 · 80 RICHMOND STREET WEST, SUITE 1100, TORONTO, M5H 2A4 · 416.867.1234
Summary
Galibier Capital Management Ltd. reported $251M in U.S.-listed holdings across 31 positions for Q3 2019.
Its largest position, CM, represents 13.1% of the portfolio.
Compared with Q2 2019, the fund opened 1 new position and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.1% · $239M
- ADR · 3.7% · $9M
- NY Reg Shrs · 0.7% · $2M
- Other · 0.5% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ABBVABBVIE INC | NEW | +190.2K | 190.2K | +$14M | $14M |
| AIGAMERICAN INT'L GROUP | SOLD OUT | −32.1K | 0 | −$2M | $0 |
| MEDTRONIC PLC | TRIMMED | −103.2K | 11.2K | −$10M | $1M |
| ENBENBRIDGE INC | ADDED | +152.4K | 547.5K | +$5M | $19M |
| NTRNUTRIEN LTD | ADDED | +152.8K | 607.2K | +$6M | $30M |
| BUDANHEUSER BUSCH INBEV SA/NV | TRIMMED | −8.6K | 18.9K | −$638,000 | $2M |
| BNSBANK N S HALIFAX | ADDED | +41.1K | 197.1K | +$3M | $11M |
| AZNNASTRAZENECA PLC | ADDED | +11.4K | 57.2K | +$658,000 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $300M | 38 | Oct 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $333M | 38 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $321M | 37 | Apr 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $350M | 37 | Jan 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $443M | 43 | Oct 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $402M | 42 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $418M | 40 | Apr 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $386M | 36 | Jan 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $450M | 38 | Oct 23, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $436M | 36 | Jul 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $423M | 39 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $493M | 43 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $496M | 41 | Oct 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $528M | 40 | Jul 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $744M | 42 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $697M | 42 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $730M | 42 | Oct 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $744M | 42 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $666M | 39 | May 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $578M | 38 | Jan 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $425M | 39 | Oct 26, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $312M | 36 | Aug 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $230M | 39 | Apr 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $315M | 35 | Jan 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $251M | 31 | Nov 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $220M | 31 | Aug 2, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $168M | 31 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $146M | 30 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.